We have collected information about Microcapsule Drug Delivery for you. Follow the links to find out details on Microcapsule Drug Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093624/
Microparticulate drug delivery systems are an interesting and promising option when developing an oral controlled release system. The objective of this paper is to take a closer look at microparticles as drug delivery devices for increasing efficiency of drug delivery, improving the release profile and drug targeting.
https://www.sciencedirect.com/science/article/pii/S2405653716301361
1. Introduction. The nano- and microcapsules are currently promising systems for drug delivery in the treatment of many types of diseases .Nano- and microcarriers have also been employed as imaging tools that makes possible to increase imaging resolution and highlights small lesions which are undetectable with traditional methods , .. In the case of the administration of drugs using nano- and ...Author: M.Y. Koroleva, T.Y. Nagovitsina, D.A. Bidanov, O.S. Gorbachevski, E.V. Yurtov
https://www.researchgate.net/publication/335091544_Microparticles_Microspheres_and_Microcapsules_for_Advanced_Drug_Delivery
Microparticles are generally in the 1–1000 µm size range, serve as multiunit drug delivery systems with well-defined physiological and pharmacokinetic benefits in order to improve the ...
https://www.sciencedirect.com/science/article/pii/S0025556419300495
Predicting the release performance of a drug delivery device is an important challenge in pharmaceutics and biomedical science. In this paper, we consider a multi-layer diffusion model of drug release from a composite spherical microcapsule into an external surrounding medium.Author: Elliot J. Carr, Giuseppe Pontrelli
https://www.pnas.org/content/111/45/16071
Nov 11, 2014 · Localized drug delivery devices provide high drug concentrations to the tumor site while preventing drug degradation and clearance until its release (7, 8). The efficacy of current intracranial drug delivery, such as Carmustine wafers, has promise, with a doubling of median survival from 9 to 20 mo in the case of Carmustine wafers (6, 9, 10).Author: Urvashi M. Upadhyay, Betty Mae Tyler, Yoda Patta, Robert Wicks, Kevin Spencer, Alexander Scott, Byro...
https://www.researchgate.net/publication/235924354_Microencapsulation_-_A_Novel_Approach_in_Drug_Delivery_A_Review
Microencapsulation – A Novel Approach in Drug Delivery: A Review ... A well designed controlled drug delivery system can overcome some of the problems of conventional therapy and enhance the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234553/
Nov 11, 2014 · Localized drug delivery devices provide high drug concentrations to the tumor site while preventing drug degradation and clearance until its release (7, 8). The efficacy of current intracranial drug delivery, such as Carmustine wafers, has promise, with a doubling of median survival from 9 to 20 mo in the case of Carmustine wafers (6, 9, 10).Author: Urvashi M. Upadhyay, Betty Mae Tyler, Yoda Patta, Robert Wicks, Kevin Spencer, Alexander Scott, Byro...
http://pubs.acs.org/doi/abs/10.1021/acs.nanolett.6b04523
Targeting of nanoparticles to distant diseased sites after oral delivery remains highly challenging due to the existence of many biological barriers in the gastrointestinal tract. Here we report targeted oral delivery of diverse nanoparticles in multiple disease models, via a “Trojan horse” strategy based on a bioinspired yeast capsule (YC).Author: Xing Zhou, Xiangjun Zhang, Songling Han, Yin Dou, Mengyu Liu, Lin Zhang, Jiawei Guo, Qing Shi, Gengh...
https://pdfs.semanticscholar.org/8ab8/f4fe0c5683b3b7997b277f8cc13d2a0f92bb.pdf
Novel drug delivery systems have several advantages over conventional multi dose therapy. Much research effort in developing novel drug delivery system has been focused on controlled release and sustained release dosage forms. Now considerable efforts are being made to deliver the drug in such a manner so as to get optimum benefits.
https://www.mdpi.com/2218-0532/87/3/20/pdf
multiparticulate drug delivery systems, o ering both therapeutic and technological advantages. Microparticles are generally in the 1–1000 m size range, serve as multiunit drug delivery systems with well-defined physiological and pharmacokinetic benefits in order to improve the e ectiveness, tolerability, and patient compliance.Author: Miléna Lengyel, Nikolett Kállai-Szabó, Vince Antal, András József Laki, István Antal
Searching for Microcapsule Drug Delivery?
You can just click the links above. The data is collected for you.
